MedTech suppliers can do the hard part: develop products that solve real clinical and operational problems. The next challenge is getting those innovations into the NHS in a way that is scalable, compliant, and easy for buyers to adopt.
The NHS Supply Chain Innovation DPS is one route to market designed for that purpose. It gives NHS organisations a structured way to consider innovative medical technologies, while suppliers can apply through a dynamic system rather than waiting for a fixed framework window. To make the most of it, your documentation needs to be clear, evidence-led, and procurement-ready so evaluators can see the outcomes, the value, and the practicalities of implementation.
A Dynamic Purchasing System (DPS) is a public sector procurement route that stays open for new suppliers to join, rather than being limited to a single “application window”. The NHS Supply Chain Innovation DPS applies that approach specifically to innovative medical technologies, with the aim of streamlining access to new solutions while keeping the process compliant and assured.
If you are used to thinking in terms of frameworks, the key distinction is this: once a framework is live, new suppliers typically cannot be added. A DPS is the exception because it is designed to remain open.
That difference matters because it changes how you plan resourcing, evidence, and timing. With a framework, you often build towards one fixed deadline. With a DPS, readiness and consistency become the advantage.
Here’s the practical way to think about it:
So being “on the DPS” is not the finish line. It is the point where your route to market becomes real.
It’s not a shortcut around due diligence. The Innovation DPS is still a procurement process, and NHS buyers still need confidence around outcomes, value, implementation and risk. NHS Supply Chain also describes the Innovation DPS as different to a framework because it allows new suppliers to join at any time over a multi-year period, while simplifying the approval process for innovative products.
Innovation rarely fits neatly into a four-year cycle. Evidence evolves, products iterate, and new clinical needs emerge. A dynamic system is built to handle that reality because suppliers can apply as they become ready, rather than waiting for a re-tender.
This also links closely with how many teams think about frameworks in the NHS more broadly: timing, eligibility, and how procurement routes shape your bid plan.
The Innovation DPS is built for suppliers with medical technologies that can demonstrate a meaningful improvement. That can include better clinical outcomes, safer delivery, increased capacity, reduced unwarranted variation, or a measurable operational benefit.
In practice, it tends to suit products and solutions that meet three broad criteria.
You need to be able to explain the problem in NHS terms, then show what changes when your technology is introduced. That might be a pathway bottleneck, a patient safety risk, or a recurring cost pressure. The strongest propositions link the innovation directly to a practical, NHS-facing outcome.
Innovation narratives often start with features. Procurement decisions start with proof. The Innovation DPS route expects suppliers to substantiate claims and present information in a way that supports evaluation and assurance.
That does not always mean you need the same level of evidence for every product, but it does mean you need the right evidence for your claims, and you need it presented consistently.
Even when the product is compelling, adoption can slow down if mobilisation is unclear. NHS buyers will look for signals that implementation is realistic and supported. Think training, onboarding, service wrap, maintenance, integration, and how you manage change in busy clinical environments.
“Innovation” in this context is not limited to brand-new inventions. It can also include established technologies used in a new way, or improvements that materially shift outcomes, efficiency, or usability. What matters is whether you can demonstrate the impact clearly and stand it up under scrutiny.
The Innovation DPS is a route to market that connects innovation assessment, procurement assurance, and then buying activity through call-offs. At a high level, there are three moving parts.
NHS Supply Chain is the procurement partner for the NHS Innovation Service for suppliers. That matters because the Innovation DPS is closely tied to how innovations are submitted, reviewed and routed.
In practice, suppliers typically come into the Innovation DPS through one of the routes described by the NHS Innovation Service:
This is where many bids start to succeed or fail. If your product positioning, evidence and claims do not line up from day one, you end up rewriting at speed later, usually under a tender deadline.
Once reviewed, NHS Supply Chain describes advising whether a submission is a “true innovation” and, if it is, informing the innovator of the best route to market and supplying a unique reference number (URN).
This is a useful way to think about what the process is trying to achieve. The Innovation DPS is designed to bring innovative products into a compliant commercial route, but only where the innovation case can be evidenced and supported.
Being accepted onto the DPS is the entry point. Winning work typically comes through opportunities that follow, where you still need to respond well, meet the requirements, and outscore competitors.
This is why readiness beats last-minute effort. A strong supplier approach usually includes:
Even with a strong product, the process can stall when documentation is not procurement-ready. Common friction points include:
Those issues are fixable, but they are much easier to solve early, before an opportunity is live.
Innovation submissions are assessed through a procurement lens. Your response needs to make it easy for evaluators to see three things quickly: what changes, why it matters, and how it will work in practice.
Start with the impact, but keep it grounded.
Avoid broad statements like “improves efficiency” unless you can attach a mechanism and a metric. The most persuasive responses use plain language and concrete measures that a clinical or procurement reader can validate.
NHS buyers will look at value in the round. That includes financial impact, but also service impact.
Common value angles that tend to land well include:
If you only talk about price, you risk underselling the full benefit. If you only talk about outcomes, you risk leaving procurement with unanswered questions. The value case needs to connect both, cleanly and consistently.
Even strong innovations can struggle when mobilisation is vague. Evaluators need confidence that adoption is realistic in a busy NHS environment.
A procurement-ready implementation plan typically covers:
This is also where supplier capability comes through. You are showing how you will support adoption at scale, not just what the product does.
Innovation does not remove the need for assurance. You will often need to evidence things like:
If you have relevant NICE guidance or evidence alignment, reference it in a way that is accurate and easy to follow. The NHS Innovation Service highlights NICE alignment as part of the wider adoption and procurement picture, which can strengthen how buyers interpret the evidence you present.
One of the simplest ways to improve scoring is consistency. Evaluators read a lot of submissions, quickly. If your core claims, numbers, or delivery model shift between sections, it creates doubt and drags scores down.
A good sense-check is to ask:
If those three line up, evaluation becomes easier and scoring typically improves.
Most suppliers do not lose out because the product is weak. They lose out because the written case is unclear, inconsistent, or difficult to evaluate. These are the issues we see most often with Innovation DPS and wider NHS procurement routes, plus the fixes that usually make the biggest difference.
It’s common to have studies, audits, case data, testimonials, and performance information, but still score poorly because the response does not connect the dots.
What helps:
Innovation messaging often focuses on what is new. Evaluators also need to understand what is practical.
What helps:
A common red flag is when mobilisation reads like a list of intentions rather than a delivery plan.
What helps:
If you already manage a pipeline across healthcare tenders, this is one of the most reliable ways to reduce last-minute rewriting when an opportunity moves quickly.
A DPS can create busy periods where multiple calls land close together. That is where quality often slips, simply because the team runs out of time.
What helps:
This is exactly where structured bid management support can protect quality while keeping the pace.
Suppliers sometimes provide correct information, but miss what the evaluator is actually scoring.
What helps:
Innovation DPS opportunities can move quickly. Evidence needs to be consistent. Inputs need to be chased, shaped, and signed off. Submissions need to land on time, be easy to evaluate, and be strong enough to win.
That is where we come in.
Some teams need capacity. Others need stronger structure, sharper writing, or better control of reviews and approvals. We plug in where it makes the biggest difference, without creating noise or slowing you down.
We turn your technical and clinical input into clear, evaluator-friendly responses, mapped to the scoring criteria. The focus stays on outcomes, value, implementation, and assurance, written in a way that is easy to follow and hard to misinterpret.
Our bid management support brings structure from kick-off to final submission, so responsibilities are clear, actions are tracked, drafts are controlled, and quality stays consistent.
If you want to improve consistency and reduce firefighting over time, we support capability building through training and mentoring for in-house teams. This is practical and applied, focused on planning, writing, and managing bids in a way that improves clarity and scoring.
Healthcare procurement has its own language, expectations, and assurance requirements. Our healthcare specialists support bids across NHS, ICB and Local Authority opportunities, combining bid strategy, solution design and expert writing.
That specialism also helps when you are working across adjacent areas of healthcare procurement. For example, the same evaluator concerns that show up in the Innovation DPS often appear in orthodontic tenders too: mobilisation, governance, patient safety, workforce resilience, and performance delivery.
Rather than listing features, here are the practical outcomes clients typically use us for:
Not exactly. A framework typically has a fixed tender window, then stays closed to new entrants until it is re-tendered. A DPS is designed to stay open, so suppliers can apply to join during its lifetime. NHS Supply Chain positions the Innovation DPS in those terms, as an alternative route that allows new suppliers to join over a multi-year period.
No. Acceptance is the first gate. Buying activity happens later through call-offs or further competition when opportunities arise. Planning matters because you still need to respond strongly when those opportunities land, with clear answers that match the evaluation criteria and your supporting evidence.
SMEs can apply. NHS Supply Chain explicitly describes the Innovation DPS as reducing barriers for suppliers, particularly small and medium-sized enterprises, by keeping the system open and simplifying the process.
The NHS Innovation Service guidance describes the Innovation DPS as open to innovations submitted to the NHS Innovation Service, reviewed and accepted by NHS Supply Chain, or referred via a Health Innovation Network (HIN).
It depends on the innovation and the route being used, but the NHS Innovation Service procurement guidance states that the technology must meet national policy objectives and have a NICE recommendation for the Innovation DPS route it describes.
If NICE evidence is relevant for your product, it should be referenced accurately and consistently, then reflected in the way you describe outcomes, value and implementation.
The Innovation DPS is a formal procurement route, so you can see it referenced in Find a Tender notices, including the contract notice for the Medical Technology (MedTech) Innovation DPS issued by Supply Chain Coordination Ltd (NHS Supply Chain).
Clarity and consistency. Evaluators need to find answers quickly, see evidence against claims, and understand implementation without making assumptions. When the narrative, metrics, and delivery model stay aligned across the response, scoring tends to improve because the submission is easier to assess.
The NHS Supply Chain Innovation DPS can be a practical route to market for MedTech innovations, particularly when you have the right evidence and a clear plan for implementation. The detail matters. Your outcomes need to be specific, your value case needs to be transparent, and your documentation needs to stay consistent from first claim to final attachment.
If you want to strengthen how you approach Innovation DPS opportunities, we can help you plan, write and manage bids that are easier to evaluate and more likely to score well. Get in touch with Bidding today to discuss how we can support you.
Bidding Ltd © 2026
